Farewell to pharma freebies?

Massachusetts may become the first state with a complete ban on pharmaceutical company freebies to doctors. The president of the Massachusetts Senate, linkurl:Therese Murray;http://www.mass.gov/legis/member/t_m0.htm (D), yesterday (March 3) filed a bill that seeks to reduce linkurl:conflicts of interest;http://www.the-scientist.com/blog/display/54300/ and healthcare costs by stemming the flow of gifts from pharmaceutical companies to doctors in the state, according to linkurl:__The Boston Globe

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Massachusetts may become the first state with a complete ban on pharmaceutical company freebies to doctors. The president of the Massachusetts Senate, linkurl:Therese Murray;http://www.mass.gov/legis/member/t_m0.htm (D), yesterday (March 3) filed a bill that seeks to reduce linkurl:conflicts of interest;http://www.the-scientist.com/blog/display/54300/ and healthcare costs by stemming the flow of gifts from pharmaceutical companies to doctors in the state, according to linkurl:__The Boston Globe__.;http://www.boston.com/news/health/articles/2008/03/04/ban_on_gifts_to_doctors_sought/?page=1 This means that everything from free journal subscriptions and paid travel expenses to swag such as note pads and pens bearing the logo of the latest pain medication would be off limits for pharmaceutical companies to offer and for doctors to accept. Distributing free samples of new drugs that physicians could offer to their patients would, however, still be allowed. According to the bill, violators of the ban would face a $5,000 fine, two years in jail, or both. Other states, including Vermont and Minnesota, have enacted laws that require pharmaceutical companies to disclose the value of such gifts over $25 and that place a $50 limit on drug company gifts to physicians, respectively. Murray filed the bill as part of healthcare reform legislation that includes measures requiring MA doctors to keep electronic medical records by 2015, mandating public reviews of insurance companies trying to raise annual premiums by more than 7 percent, among other rules.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform